33 results on '"Giardina, Paul A."'
Search Results
2. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
3. A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
4. Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
5. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
6. Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
7. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
8. Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
9. Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
10. Data from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
11. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
12. Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
13. A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
14. Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations
15. Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
16. MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
17. Tissue-Specific Landscape of the Human T Cell Repertoire in Graft-Versus-Host Disease
18. The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies
19. MAIT and Vδ2 Unconventional T Cells Predict Favorable Outcome after Allogeneic HCT and Are Supported By a Diverse Intestinal Microbiome
20. TCR Repertoires in Graft-Versus-Host-Disease (GVHD)-Target Tissues Reveals Tissue Specificity of the Alloimmune Response
21. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
22. Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.
23. Intestinal Microbiota Composition and Diversity Are Associated with CD4 T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation
24. A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract
25. The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation
26. 96 - Intestinal Microbiota Composition and Diversity Are Associated with CD4 T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation
27. Low-Level Radioactive Waste from Rare Metals Processing Facilities
28. A Review of Joseph J. Mangano’s Study on the Variation in Thyroid Cancer Incidence
29. Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis.
30. 467. Comparing custodial and democratic treatment programs
31. Comparing Custodial and Democratic Treatment Programs
32. Sugar-rich foods exacerbate antibiotic-induced microbiome injury.
33. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.